The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Volkow, N. D.
* Articles by Pappas, N.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Volkow, N. D.
* Articles by Pappas, N.
Related Collections
* Neurophysiology
* Neurotransmitters
* Other Somatic Therapy
* PET

Am J Psychiatry 1997; 154:50-55
Copyright © 1997 by American Psychiatric Association


REGULAR ARTICLES

Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors

ND Volkow, GJ Wang, JS Fowler, J Logan, B Angrist, R Hitzemann, J Lieberman and N Pappas
Medical and Chemistry Departments, Brookhaven National Laboratory, Upton, N.Y. 11973, USA. volkow@brain.med.bnl.gov

OBJECTIVE: The authors' goals were to determine whether baseline dopamine activity contributes to response to methylphenidate and to assess the pattern of metabolic responses associated with enhanced dopamine activity. METHOD: They used positron emission tomography with 2-deoxy-2[18F]fluoro-D-glucose to evaluate the effects of two sequential doses of methylphenidate on brain metabolism in 15 healthy subjects. Dopamine D2 receptor availability was measured with [11C]raclopride to evaluate its relation to methylphenidate-induced metabolic changes. RESULTS: Methylphenidate increased brain metabolism in six subjects, decreased it in two, and did not change it in seven; however, it consistently increased cerebellar metabolism. Methylphenidate significantly increased "relative" (region relative to the whole brain) metabolism in the cerebellum and decreased it in the basal ganglia. Regional metabolic changes in the cerebellum and the frontal and temporal cortices were significantly correlated with D2 availability. Frontal and temporal metabolism were increased in subjects with high D2 receptors and decreased in subjects with low D2 receptors. CONCLUSIONS: Methylphenidate induced variable changes in brain metabolism, but it consistently increased cerebellar metabolism. It also induced a significant reduction in relative metabolism in the basal ganglia. The significant association between metabolic changes in the frontal and temporal cortices and in the cerebellum and D2 receptors suggests that methylphenidate's metabolic effects in these brain regions are due in part to dopamine changes and that differences in D2 receptors may be one of the mechanisms accounting for the variability in response to methylphenidate.


This article has been cited by other articles:


Home page
Journal of Family IssuesHome page
M. Taylor, S. Houghton, and K. Durkin
Getting Children With Attention Deficit Hyperactivity Disorder to School on Time: Mothers' Perspectives
Journal of Family Issues, July 1, 2008; 29(7): 918 - 943.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
J. D. Gray, M. Punsoni, N. E. Tabori, J. T. Melton, V. Fanslow, M. J. Ward, B. Zupan, D. Menzer, J. Rice, C. T. Drake, et al.
Methylphenidate Administration to Juvenile Rats Alters Brain Areas Involved in Cognition, Motivated Behaviors, Appetite, and Stress
J. Neurosci., July 4, 2007; 27(27): 7196 - 7207.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. D. Volkow, G.-J. Wang, Y. Ma, J. S. Fowler, C. Wong, Y.-S. Ding, R. Hitzemann, J. M. Swanson, and P. Kalivas
Activation of Orbital and Medial Prefrontal Cortex by Methylphenidate in Cocaine-Addicted Subjects But Not in Controls: Relevance to Addiction
J. Neurosci., April 13, 2005; 25(15): 3932 - 3939.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
R. van Reekum, D. T. Stuss, and L. Ostrander
Apathy: Why Care?
J Neuropsychiatry Clin Neurosci, February 1, 2005; 17(1): 7 - 19.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. D. Volkow, G.-J. Wang, Y. Ma, J. S. Fowler, W. Zhu, L. Maynard, F. Telang, P. Vaska, Y.-S. Ding, C. Wong, et al.
Expectation Enhances the Regional Brain Metabolic and the Reinforcing Effects of Stimulants in Cocaine Abusers
J. Neurosci., December 10, 2003; 23(36): 11461 - 11468.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
M. Weiss and C. Murray
Assessment and management of attention-deficit hyperactivity disorder in adults
Can. Med. Assoc. J., March 18, 2003; 168(6): 715 - 722.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
F. X. Castellanos
Proceed, with Caution: SPECT Cerebral Blood Flow Studies of Children and Adolescents with Attention Deficit Hyperactivity Disorder
J. Nucl. Med., December 1, 2002; 43(12): 1630 - 1633.
[Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
C. M. Anderson, A. Polcari, S. B. Lowen, P. F. Renshaw, and M. H. Teicher
Effects of Methylphenidate on Functional Magnetic Resonance Relaxometry of the Cerebellar Vermis in Boys With ADHD
Am J Psychiatry, August 1, 2002; 159(8): 1322 - 1328.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
F. X. Castellanos, J. N. Giedd, P. C. Berquin, J. M. Walter, W. Sharp, T. Tran, A. C. Vaituzis, J. D. Blumenthal, J. Nelson, T. M. Bastain, et al.
Quantitative Brain Magnetic Resonance Imaging in Girls With Attention-Deficit/Hyperactivity Disorder
Arch Gen Psychiatry, March 1, 2001; 58(3): 289 - 295.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
N. D. Volkow, J. Logan, J. S. Fowler, G.-J. Wang, R. C. Gur, C. Wong, C. Felder, S. J. Gatley, Y.-S. Ding, R. Hitzemann, et al.
Association Between Age-Related Decline in Brain Dopamine Activity and Impairment in Frontal and Cingulate Metabolism
Am J Psychiatry, January 1, 2000; 157(1): 75 - 80.
[Abstract] [Full Text]


Home page
Am. J. PsychiatryHome page
N. D. Volkow, G.-J. Wang, J. S. Fowler, R. Hitzemann, B. Angrist, S. J. Gatley, J. Logan, Y.-S. Ding, and N. Pappas
Association of Methylphenidate-Induced Craving With Changes in Right Striato-orbitofrontal Metabolism in Cocaine Abusers: Implications in Addiction
Am J Psychiatry, January 1, 1999; 156(1): 19 - 26.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
N. D. Volkow, G.-J. Wang, J. S. Fowler, S. J. Gatley, J. Logan, Y.-S. Ding, S. L. Dewey, R. Hitzemann, A. N. Gifford, and N. R. Pappas
Blockade of Striatal Dopamine Transporters by Intravenous Methylphenidate Is Not Sufficient to Induce Self-Reports of "High"
J. Pharmacol. Exp. Ther., January 1, 1999; 288(1): 14 - 20.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. J. Vaidya, G. Austin, G. Kirkorian, H. W. Ridlehuber, J. E. Desmond, G. H. Glover, and J. D. E. Gabrieli
Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study
PNAS, November 24, 1998; 95(24): 14494 - 14499.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
T. Pohjalainen, J. O. Rinne, K. Någren, E. SyvÄlahti, and J. Hietala
Sex Differences in the Striatal Dopamine D2 Receptor Binding Characteristics in Vivo
Am J Psychiatry, June 1, 1998; 155(6): 768 - 773.
[Abstract] [Full Text]


Home page
Am. J. PsychiatryHome page
Decline of Dopamine: Effects of Age and Acute Neuroleptic Challenge
Am J Psychiatry, March 1, 1998; 155(3): 319 - 323.
[Full Text]


Home page
J PsychopharmacolHome page
E. J. Garland
Reviews : Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats
J Psychopharmacol, January 1, 1998; 12(4): 385 - 395.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1997 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org